Polymyxin B and Colistin Dosing in Patients with Normal Renal Function
For patients with normal renal function, polymyxin B should be dosed at 1.5-3 mg/kg/day divided into 2 doses with a loading dose of 2-2.5 mg/kg, while colistin (polymyxin E) should be administered with a loading dose of 6-9 million IU followed by 4.5 million IU every 12 hours. 1, 2, 3
Polymyxin B Dosing
Standard Dosing
- Loading dose: 2-2.5 mg/kg 1
- Maintenance dose: 1.5-3 mg/kg/day divided into 2 doses 1
- FDA labeling recommends 15,000 to 25,000 units/kg/day for adults with normal renal function 3
- Note: 1 mg of polymyxin B = 10,000 units
Administration
- Can be administered as continuous infusion 1
- Intravenous administration is preferred over intramuscular due to severe pain at injection sites 3
- Dosing should be based on actual body weight, though some guidelines suggest using ideal body weight for obese patients 2
Colistin (Polymyxin E) Dosing
Standard Dosing
- Loading dose: 6-9 million IU (equivalent to 5 mg/kg colistin base activity) 1, 2
- Loading dose should be administered to all patients regardless of renal function
- Maintenance dose: 9 million IU/day divided into 2-3 doses 1
- Typically administered as 4.5 million IU every 12 hours 2
- FDA labeling recommends 2.5-5 mg/kg/day of colistin base activity divided into 2-4 doses 4
Administration
- Administered as colistimethate sodium (CMS), which is the inactive prodrug of colistin
- Extended interval dosing (4.5 million IU every 12 hours) is recommended for critically ill patients 2
- Important conversion: 1 million IU of colistin is equivalent to approximately 80 mg of CMS or 30 mg of colistin base activity 1, 2
Clinical Considerations
Pharmacokinetic Considerations
- Polymyxin B clearance is not significantly affected by renal function, with recent studies showing comparable drug exposure in patients with normal and impaired renal function 5, 6
- Colistin requires a loading dose because plasma concentrations may be suboptimal for 2-3 days before reaching steady state 1
- Polymyxin B may be preferred over colistin in patients with renal impairment as it doesn't require dosage adjustments based on renal function 1, 6
Monitoring
- Close monitoring of renal function is essential during therapy with both agents, as 14-20% of patients may develop acute kidney injury 2
- Therapeutic drug monitoring may be beneficial but is not widely available
Common Pitfalls
- Inconsistent dosing units: Colistin may be prescribed in different units (IU vs. mg), which can lead to dosing errors 2
- Inadequate loading doses: Failure to administer loading doses can result in suboptimal plasma concentrations for several days 1
- Inappropriate renal dose adjustments for polymyxin B: Unlike colistin, polymyxin B dosing should not be adjusted based on renal function 6
Indications and Duration
- Reserved for infections caused by multidrug-resistant gram-negative bacteria
- Treatment duration depends on infection site:
- Complicated urinary tract infections: 5-10 days
- Complicated intra-abdominal infections: 5-10 days
- Ventilator-associated or hospital-acquired pneumonia: 10-14 days
- Bacteremia: 10-14 days 2
Both polymyxin B and colistin are critical last-line antibiotics for multidrug-resistant gram-negative infections, and their use should be guided by antimicrobial susceptibility testing and, when possible, infectious disease consultation.